Final programme
Thursday May 8
9,00-12,00 - Minimally invasive surgery
(ERBE, Medtronic, Omni-Guide)
Instructional Videopresentations
Workshops (sialoendoscopy)
12,00-14,30 - Guided poster tour
13,00-14,30 - Lunch
14,30-15,30 - Genzyme Satelite Symposium: Thyroid Cancer Management - Time to think beyond the
malignancy?
15,45-16,45 - Irx Satelite Symposium: Advancing
the rolle of immunotherapy in head and neck cancer
17,00-18,30 - Merck Serono Satelite Symposium: ERBITUX - Evolving treatment standard in head and neck cancer
19,00 - Opening Ceremony
Amando Ivančić - Symphony in G-dur
Ivan Mane Jarnović - Quartet nr.1 in F-dur
Juraj Karlo Wisner - Morgenstern - Quatuor progressif
Performers: All - Female String Quartet of the Croatian Music Institute's Social Orchestra
19,30 - Welcome Reception (Sponsored by Merck Serono)
Friday May 9
08.00 - 10.10 FREE TOPICS
THE ROLE OF PET -SCANING IN HEAD AND NECK TUMOURS
Chairs: Knecht R., Fliss D., Klosar J.
08.00 - 08.10 Combined PET/CT for Glucose Metabolism and Perfusion: Bisdas S., Germany
08.10 - 08.20 Reproducibility of SUV ratios in 18F-FDG PET/CT studie: Bisdas S., Germany
08.20 - 08.30 Accuracy of PET/CT for Recurrent Skull Base Malignancies: Bisdas S. Germany
ORAL CAVITY / OROPHARYNX
Chairs: Knecht R., Fliss D., Klosar J.
08.30- 08.40 Role of lymphoscintigraphy and SLN in management of OSCC; Barth E.-L, Germany
08.40- 08.50 How many nodes are needed to stage a neck? ; Kohler H.F., Brazil
08.50-09.00 CIN in OSCC resection margins predicts risk for recurrence; Bergshoeff V. E., The
Netherlands
09.00-09.10 Funcional reconstruction of the oral cavity with RFFF, Kim M.-S-Korea
09.10-09.20 Neoadjuvant chemotherapy in advanced oral squamous cancer.; Chaukar D., India
09.20-09.30 Mucosal melanomas of oral cavity; Chaturvedi P., India
09.30-09.40 Survival after surgery for oral cavity cancer; Woolgar J., UK
09.40-09.50 Squamous Cell Carcinoma of the Tonsillar Remnant (SCCTR); Simo R., UK
09.50-10.00 Chromosome 1 and 7 changes in HPV positive and negative TSCC; Mooren J.J., The
Netherlands
10.00-10.10 Risk and prognostic factors in HNSCC and HPV infection; Klozar J.;Czech Republic
10.10 - 10.30 Coffee break
10.30 - 13.00 PLENARY SESSION: Cutaneous malignancies
Chair: Virag M., Croatia Co-Chair: Shenoy A.M., India
10.30-11:00 Keynote Lecture: Sentinel node biopsy for head and neck melanoma; H. de Wilt, The Netherlands
11:00 - 12.00 Oral presentations
11.00-11.10 Sentinel lymph node biopsy for melanomas of H&N region; Pilko G., Slovenia
11.10-11.30 Who is responsible for incurable skin cancer: the tumor, the patient or the surgeon?,
Virag M, Croatia
11.30-11.40 Major reconstructions for head/neck cutaneous tumour excison; Jeremic J., Serbia
11.40.-11.50 Extensive defect reconstruction after cutaneous malignancies ; Costan V.V., Romania
11.50-12.00 Skin involvement from Metastatic Lymph Nodes in H & N Cancer; Orabi A. A., UK
12:00 - 12.15 Poster presentations
12.00-12.05 Hedgehog signalling pathway in Merkel Cell Carcinoma; Brunner M., Austria
12.05-12.10 Effect of Resveratrol in Merkel cell carcinoma; Heiduschka G., Austria
12.10-12.15 Metastases of skin tumours in great salivary glands; Kavečanský V., Slovakia
12.15 - 12.30 Conclusion Remarks: Teymoortash A. (Germany)
12.30- 12.50 Neck Dissection: An Operation in Evolution; Myers E. N., USA
13.00 - 14.00 Lunch
14.00 - 15.45 PLENARY SESSION: Management of Persistent Disease
Chair: de Bree R. ,The Netherlands Co-chair: Licitra L. , Italy
14.00 - 14:30 Keynote Lecture: Nicolai P., Italy
14.30 - 15.30 Oral presentations
14.30-14.40 HLTF is a predictor of recurrence in Head and Neck Cancers; Saussez S.,Belgium
14.40-14.50 Use of Ultrasound for Post-therapeutic follow-up of HNC; Albers A. E., Germany
14.50-15.00 CT Predicts Residual Nodal Disease after Radiation Therapy; Glavina G.; Croatia
15.00-15.10 Baseline Perfusion CT Predicts Chemoradiation Outcome ; Bisdas S., Germany
15.10-15.20 PET/CT for Treated Oral Cavity and Oropharyngeal Cancer; Glavina G., Croatia
15.20-15.30 PDT in Advanced Head and Neck Cancer: a Multicenter Study; Vander Poorten V., Belgium
15.30 - 15.45 Conclusion Remarks: Knecht R., Germany
15.45 - 16:05 Coffee Break
16:05 -17:15 FREE TOPICS
THYROID CANCER
Chairs: Spriano G., Romanichshien A., Paunović I.
16.05-16.15 The Effectivenes of Peripheral Thyropin Receptor mRNA in the Follow-up of
Differentiated Thyroide Cancer; Milas K.,USA
16.15-16.25 Serum Galectins-1 and -3 levels in Nodular Thyroid Disease; Saussez S. Belgium
16.25-16.35 Pathological types of thyroid cancer - years ago and nowadays; Diklic A ; Serbia
16.45-16.45 MIVAT- how to use in thyroid cancer ; Bura M; Croatia
16.45-16.55 Prognostic factors in advanced thyroid cancer.; Spriano G, Italy
16.55-17.05 Crico- tracheal resection and anastomosis for thyroid cancer; Piazza C., Italy
17.05-17.15 Surgical Management of thyroid hurthle cell tumours; Paunovic I, Serbia
17.30 - 19:00 General Assembly of EHNS
20.30 Conference Dinner
Saturday May 10
08.00 - 10.20 FREE TOPICS
RECONSTRUCTION AFTER MAJOR HEAD AND NECK SURGERY
Chairs: Reshetov I.V., Uglješić V., Lanišnik B.
08.00-08.10 Craniofacial tumours, The operation and reconstruction; Reshetov I.V., Russia
08.10-08.20 Variants of surgical treatment craniofacial malignant tumours ; Reshetov I.V., Russia
08.20-08.30 Rehabilitation of combined defects in head and neck; Kropotov M.A ; Russia
08.30-08.40 Cancer of the buccal mucosa: choice of the plastic material; Kropotov M. A. ; Russia
08.40-08.50 Dynamic lower lip reconstruction with free gracilis flap; D'arpa S., Italy
08.50-09.00 Flap design for tongue reconstruction: a series of 70 cases; Mallet Y., France
09.00-09.10 Extended Karapadzic method for the reconstruction of composite lower lip, chin
and facial defects, Uglešić V., Croatia
09.10-09.20 Perforator flaps in Head & Neck Reconstruction; Zubčić V. Croatia
CHEMOTHERAPY / RADIOTHERAPY
Chairs: Dietz A., Shenoy A.M., Rakušić Z.
09.20-09.30 Endoscopic Laser Surgery for Hypopharyngeal Carcinoma; Thurnher D ; Austria
09.30-09.40 Chemoradiation in advanced oral cancer: 10-year-follow-up; Sinikovic B. ; Germany
09.40-09.50 Induction chemotherapy for locally advanced oral cancer; Kim K. H., Korea
09.50-10.00 Concurrent chemoradiotherapy (weekle CDDP + EBRT) for organ preservation in
220 T3-4/N + HNSCC; Shenoy A.M., India
10.00-10.10 Induction Chemotherapy with paclitaxel and cisplatin following radiotherapy for larnx organ preservation in advanced laryngeal and hypopharyngeal cancer results in less late toxicity - experience of a multicenter trial in Germany (DeLOS-1); Dietz A., Germany
10.10-10.20 Radiotherapy with gemcitabine (Gem) in head and neck cancer; Specenier P.M., Belgium
10.20-10.40 Molecular targeting in radio(chemo) therapy of head and neck cancer: anti - EGFR approach and beyond, Milas L. (USA)
10:40 - 11:00 Coffee Break
11.00 - 12.45 PLENARY SESSION: Salivary Gland Tumours
Chair: Iro H., Germany Co-chair: Skálová A., Czech Republic
11:00 - 11:30 Keynote Lecture: Bradley P., UK
11:30 - 12:30 Oral presentations
11.30-11.40 Ki-67 proliferation activity of pleomorphic adenomas; Skálová A, Czech Republic
11.40-11.50 Ultrasonography of salivary gland neoplasms; Romanov I. S., Russia
11.50-12.00 FNAC of intraoral minor salivary gland tumours ; Trutin Ostović K., Croatia
12.00-12.10 Sentinel lymph node biopsy in parotid gland carcinoma ; Stárek I, Czech Republic
12.10-12.20 Carcinomas of the parotid gland. Oncological results; Chevalier D., France
12.20-12.30 Recurrent pleomorphic adenomas of the parotid gland; Barth E.L., Germany
12:30 - 12:40 Poster presentations
12.30-12.35 Acinic cell carcinoma with high grade transformation; Skálová A., Czech Republic
12.35-12.40 Extent of surgery for parotid acinic cell carcinoma; Saprina O ; Russia
12:40 - 13.00 Conclusion Remarks: Julieron M., France
13.00 - 14.00 Lunch
14.00 - 15.30 PLENARY SESSION: Management of Complications of Combined
Treatment
Chair: Spriano G., Italy Co-chair: Rapidis A.D., Greece
14:00 - 14:30 Keynote Lecture: Shah J.P., USA
14:30 - 15:00 Oral presentations
14.30-14.40 Bisphosphonate-associated osteonecrosis of the jaws; Eckardt A., Germany
14.40.-14.50 Double Barrel Fibula Reconstruct Mandible radionecrosis ; Liao G., China
14.50-15.00 Postoperative outcome of elderly ; Penel N., France
15:00 - 15:10 2 POSTER PRESENTATIONS
15.00-15.05. RSA Causing PCF following salvage laryngectomy; Orabi AA ; UK
15.05.-15.10 Determinants of postoperative length of stay (LOS); Penel N., ; France
15.10 - 15:25 Conclusion Remarks: Vermorken J.B., Belgium
15:25 - 15:30 EHNS 2012 ATHENS: Rapidis A., Greece
15:30 - 15:50 Coffee Break
15.50 - 18.30 FREE TOPICS
LARYNX / HYPOPHARYNX
Chairs: Eckel H.E., Večerina-Volić S., Ivkić M.
15.50-16.00 Radionecrosis or tumor recurrence after radiochemotherapy of laryngeal and
hypopharyngeal carcinoma", Zbären P.,Switzerland
16.00-16.10 Outcomes in patients treated by chemort or laryngectomy; Kazi R.,UK
16.10-16.20 Endoscopic partial laryngectomy for T2-T3 glottic cancer; Peretti G., Italy
16.20-16.30 Node metastasis and arytenoid fixation in laryngeal cancer ; Gallegos F, Mexico
16.30-16.40 Estimation of long lasting influence of myofascial release techniques on oesophageal pressure in patients after total laryngectomy; Golusinski W., Poland
16.40-16.50 Endoscopic horizontal partial laryngectomy by CO2 laser in the management of supraglottic squamous cell carcinoma; Almadori G, Italy
16.50-17.00 Supraglottic laryngectomy: functional and oncologic results; Milisavljevic D.;
Serbia
17.00-17.10 Radial forearm flap in reconstruction of pharyngeal canal; Lanišnik B., Slovenia
17.10-17.20 Delination of the nodal CTV; another progress in radiotherapy of head and neck
cancers; Rakušić Z.; Croatia
MISCELLANEOUS
Chairs: Kocijan G., Pešutić-Pisac V., Simo R.
17.20-17.30 FNAC or tissue biopsy? UK Head and Neck Clinical Practice; Kocjan G.; UK
17.30-17.40 Ultrasound-guided fine needle aspiration cytology of the parotid tumors; Markov - Glavaš D.; Croatia
17.40-17.50 Co-culture of monocytes with HNSCC tissue predicts prognsis; Kross K. W.; Norway
17.50-18.00 Prognostic role of expression of HER proteins in LSCC; Almadori G., Italy
18.00-18.10 Mucosal melanoma of the head and neck : report of 23 cases; Benlyazid A ; France
18.10-18.20 Sarcomas of the skull base. Prediction of outcome ; Matyakin E.G.; Russia
18.20-18.30 Timely enteral nutrition for head and neck cancer patients undergoing radiotherapy.; Carvalho A. L., Brazil
18.30-18.40 Narrow band imaging (NBI) in head and neck SCC (HNSCC); Piazza C., Italy
18.40 Closing Ceremony
Duration of oral presentations: 8 min. + 2min. discussion
Duration of oral postre short presentations: 3 min. + 2 min. discussion
Poster presentation time: 2 min.
